I Knezevic

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002
    I Knezevic
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Vaccine 22:1836-41. 2004
  2. doi request reprint The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines
    Ivana Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 40:499-506. 2012
  3. doi request reprint Biosimilars--global issues, national solutions
    Ivana Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Biologicals 39:252-5. 2011
  4. doi request reprint Evaluation of similar biotherapeutic products (SBPs): scientific principles and their implementation
    Ivana Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Biologicals 39:256-61. 2011
  5. doi request reprint Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA
    I Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 38:162-9. 2010
  6. doi request reprint Stability evaluation of vaccines: WHO approach
    Ivana Knezevic
    World Health Organization, Immunization, Vaccines and Biologicals Department, Geneva, Switzerland
    Biologicals 37:357-9; discussion 421-3. 2009
  7. doi request reprint WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007
    I Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 36:203-11. 2008
  8. ncbi request reprint WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005
    I Knezevic
    World Health Organization, Geneva, Switzerland
    Vaccine 24:3874-7. 2006
  9. doi request reprint WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Beijing, China, 7-9 November 2007
    I Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Vaccine 26:3960-8. 2008
  10. ncbi request reprint WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom
    D K L Xing
    National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK
    Vaccine 25:2749-57. 2007

Detail Information

Publications10

  1. ncbi request reprint Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002
    I Knezevic
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Vaccine 22:1836-41. 2004
  2. doi request reprint The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines
    Ivana Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 40:499-506. 2012
    ..Synergy was recognized as a significant mechanism for leveraging existing resources in responding to global public health challenges and in addressing WHO's priorities. Agreement was reached for operating as a network of CCs...
  3. doi request reprint Biosimilars--global issues, national solutions
    Ivana Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Biologicals 39:252-5. 2011
    ..It is intended as an introduction to the series of articles in this special issue of Biologicals devoted to similar biotherapeutic products...
  4. doi request reprint Evaluation of similar biotherapeutic products (SBPs): scientific principles and their implementation
    Ivana Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Biologicals 39:256-61. 2011
    ....
  5. doi request reprint Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA
    I Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 38:162-9. 2010
    ..The SG will report outcomes of its discussion to the ECBS at its next meeting in October 2009 for further considerations and advice regarding the proposed course of action...
  6. doi request reprint Stability evaluation of vaccines: WHO approach
    Ivana Knezevic
    World Health Organization, Immunization, Vaccines and Biologicals Department, Geneva, Switzerland
    Biologicals 37:357-9; discussion 421-3. 2009
    ..This article provides basic information about WHO international standards as well as key definitions and principles for stability evaluation of vaccines that are elaborated in detail in the above mentioned guidance document...
  7. doi request reprint WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007
    I Knezevic
    World Health Organization, Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, Avenue Appia, CH 1211 Geneva, Switzerland
    Biologicals 36:203-11. 2008
    ..The Study Group is working on the preparation of a revised WHO document, and a broad consultation with regulators, manufacturers, and other relevant parties is planned for 2008...
  8. ncbi request reprint WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005
    I Knezevic
    World Health Organization, Geneva, Switzerland
    Vaccine 24:3874-7. 2006
  9. doi request reprint WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Beijing, China, 7-9 November 2007
    I Knezevic
    Department of Immunization, Vaccines and Biologicals, Quality, Safety and Standards Team, World Health Organization, Avenue Appia, Geneva, Switzerland
    Vaccine 26:3960-8. 2008
    ....
  10. ncbi request reprint WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom
    D K L Xing
    National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK
    Vaccine 25:2749-57. 2007
    ..Post-marketing surveillance was recognised as an important part of overall vaccine evaluation and a unique opportunity to understand vaccine performance in the population and to establish a link with quality control...